Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (41-50 of 311) with videos related to

Pageof 32
Sort By:
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Anaplastic lymphoma kinase (<i>ALK</i>) inhibitors for second-line therapy of non-small cell lung cancerThierry Berghmans, Myriam Remmelink, Ahmad Awada
Expert Opinion on Drug Metabolism & Toxicology|February 10, 2015
Evaluating the pharmacokinetics and pharmacodynamics of everolimus for treating breast cancerAndrea Gombos, Philippe Barthélémy, Ahmad Awada
Expert Review of Anticancer Therapy|October 15, 2020
Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancerGeorges El Hachem, Andrea Gombos, Ahmad Awada
Expert Review of Anticancer Therapy|May 24, 2014
Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug reviewLaura Polastro, Philippe G Aftimos, Ahmad Awada
Current Clinical Pharmacology|April 22, 2010
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectivesOtto Metzger-Filho, Camilo Moulin, Ahmad Awada
Current Opinion in Oncology|March 14, 2012
Personalized management of patients with solid cancers: moving from patient characteristics to tumor biologyAhmad Awada, Anna M Vandone, Philippe Aftimos
Expert Opinion on Investigational Drugs|June 25, 2019
Investigational drugs in early stage clinical trials for the treatment of HER2+ breast cancerAndrea Gombos, Maria Alice Franzoi, Ahmad Awada
Future Oncology (London, England)|August 12, 2009
Changing the clinical picture of challenging tumors: tales becoming reality?Camilo Moulin, Otto Metzger-Filho, Ahmad Awada
Discovery Medicine|February 19, 2014
Molecular biology in medical oncology: diagnosis, prognosis, and precision medicinePhilippe G Aftimos, Philippe Barthelemy, Ahmad Awada
The New England Journal of Medicine|March 25, 2005
Palifermin and chemotherapy-induced oral mucositisAhmad Awada, Marie-Thérèse Genot, Jean Klastersky
Pageof 32

Showing results (41-50 of 311) with videos related to

Sort By:
Pageof 32
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Anaplastic lymphoma kinase (<i>ALK</i>) inhibitors for second-line therapy of non-small cell lung cancerThierry Berghmans, Myriam Remmelink, Ahmad Awada
Expert Opinion on Drug Metabolism & Toxicology|February 10, 2015
Evaluating the pharmacokinetics and pharmacodynamics of everolimus for treating breast cancerAndrea Gombos, Philippe Barthélémy, Ahmad Awada
Expert Review of Anticancer Therapy|October 15, 2020
Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancerGeorges El Hachem, Andrea Gombos, Ahmad Awada
Expert Review of Anticancer Therapy|May 24, 2014
Eribulin mesylate in the management of metastatic breast cancer and other solid cancers: a drug reviewLaura Polastro, Philippe G Aftimos, Ahmad Awada
Current Clinical Pharmacology|April 22, 2010
Molecular targeted therapy in prevalent tumors: learning from the past and future perspectivesOtto Metzger-Filho, Camilo Moulin, Ahmad Awada
Current Opinion in Oncology|March 14, 2012
Personalized management of patients with solid cancers: moving from patient characteristics to tumor biologyAhmad Awada, Anna M Vandone, Philippe Aftimos
Expert Opinion on Investigational Drugs|June 25, 2019
Investigational drugs in early stage clinical trials for the treatment of HER2+ breast cancerAndrea Gombos, Maria Alice Franzoi, Ahmad Awada
Future Oncology (London, England)|August 12, 2009
Changing the clinical picture of challenging tumors: tales becoming reality?Camilo Moulin, Otto Metzger-Filho, Ahmad Awada
Discovery Medicine|February 19, 2014
Molecular biology in medical oncology: diagnosis, prognosis, and precision medicinePhilippe G Aftimos, Philippe Barthelemy, Ahmad Awada
The New England Journal of Medicine|March 25, 2005
Palifermin and chemotherapy-induced oral mucositisAhmad Awada, Marie-Thérèse Genot, Jean Klastersky
Pageof 32